Scientists are learning more about this leading complication of childbirth. Treatments are improving and doctors can test for ...

Arcus Biosciences reports 26.7-month median survival and 59% response rate in Phase 2 cancer study with domvanalimab ...

JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today announced an exclusive licensing ...

The FDA has approved Kedrion Biopharma’s Qivigy, a 10% IV immunoglobulin therapy, for treating adults who have primary ...

Group sales In the first nine months of 2025, Roche achieved sales growth of 7% (2% in CHF) to CHF 45.9 billion due to strong demand for our pharmaceutical and diagnostic products.

Shattuck Labs, Inc. ( NASDAQ: STTK) The United European Gastroenterology (UEG) Congress UEG Week 2025 October 8, 2025 10:00 AM EDT ...

Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...

Splenic Rupture Post-Caesarean Section. Open Journal of Nursing, 15, 848-862. doi: 10.4236/ojn.2025.1510061 . The spleen is a ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Sabrina Karl has over two decades of experience writing about savings, CDs, and ...

Small savings schemes typically offer reliable, consistent long-term investment returns, making them the preferred choice among conservative investors. If you are looking to invest in small savings ...

Hospital-grade IV treatments are now available at strip mall clinics for anyone willing to pay. Medical professionals warn ...